BioWorld Asia

Jan. 25, 2006

SkyePharma Still Tumultuous, As Gowrie-Smith Resigns Post

LONDON - The battle for SkyePharma plc moved into war when founder Ian Gowrie-Smith resigned to forestall an attempt by activist shareholders to oust him. (BioWorld International) Read More

Lipoxen Goes Public Through Merger With Shell Greenchip

Yeast Proteome Survey Details Approach To Molecular Function

EuroGen Drops European Application For Orathecin

DBV Technologies Raises EUR12M In Second Round

Amgen Plans To Build $1B Biologics Facility In Ireland

Syntonix, Biovitrum In Deal On Long-Acting Clotting Product

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 17, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

For clonal hematopoiesis, epigenetics can be in driver’s seat

BioWorld Science

Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...

Illustration of amyloid plaques in Alzheimer's disease

Elixiron’s enrupatinib shows upbeat interim phase II AD results

BioWorld

Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...

Gene replacement rescues autism-related phenotypes in mice

BioWorld Science

Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...